Suchergebnisse - "SHEN ZHIRONG"

PubPharm (54)

1

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

enthalten in: Blood advances | 2024

von Tam, C. | Opat, S. | D'Sa, S. | +33

2

Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody Ociperlimab

enthalten in: Structure (London, England : 1993) | 2024

von Sun, J. | Zhang, X. | Xue, L. | +8

3

Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

enthalten in: Cell reports. Medicine | 2023

von Duan, J. | Zhang, Y. | Chen, R. | +19

4

BGB-A445, a novel non-ligand-blocking agonistic anti-OX40 antibody, exhibits superior immune activation and antitumor effects in preclinical models

enthalten in: Frontiers of medicine | 2023

von Jiang, B. | Zhang, T. | Deng, M. | +26

5

METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF

enthalten in: Europäisches Patentamt | 2023

von LIU YANG | WANG WEIGE | YAO HUI | +5

6

BGB-A445, a novel non-ligand-blocking agonistic anti-OX40 antibody, exhibits superior immune activation and antitumor effects in preclinical models

enthalten in: Frontiers of medicine in China | 2023

von Jiang, B. | Zhang, T. | Deng, M. | +26

7

METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF

enthalten in: Europäisches Patentamt | 2023

von YU YILING | LIU YANG | WANG WEIGE | +5

8

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors

enthalten in: Biomarker research | 2023

von Ye, D. | Desai, J. | Shi, J. | +14

9

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors

enthalten in: Biomarker Research | 2023

von Ye, D. | Desai, J. | Shi, J. | +14

10

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

enthalten in: mAbs | 2023

von Wang, Y. | Quan, Q. | Gleason, C. | +26

1
2
3
4
5
6
Nächster »
[6]